206 top medical experts on Glucagonoma across 22 countries and 8 U.S. states, including 39 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Glucagonoma: An almost always malignant glucagon-secreting tumor derived from the pancreatic alpha cells. It is characterized by a distinctive migratory erythema; weight loss; stomatitis; glossitis; diabetes mellitus; hypoaminoacidemia; and normochromic normocytic anemia.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Islet Cell Carcinoma (189).
  4. Clinical Trials ClinicalTrials.gov : at least 17 including 1 Active, 10 Completed, 1 Recruiting
  5. Synonyms: alpha-Cell Adenoma,  alpha-Cell Tumor


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Mountjoy, Luke     Google Publications
    Iowa Methodist Medical Center, Des Moines, IA .
    Physician  Case Reports 
    Subjects: Exanthema; Pancreatic Neoplasms
    Categories: Complications; Pathology
    Glucagonoma-Associated Rash. (2017)

  2. Tavakkol, Zarry   Dermatology  Google Publications
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 72/100
    Subjects: Pancreatic Neoplasms
    Categories: Diagnosis
    Images in clinical medicine. Necrolytic migratory erythema. (2010)

  3. Kaffenberger, Benjamin H   Dermatology  Google Publications
    Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Top Hospital
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 82.3/100
    Disclosed payments from biomedical company (Novartis Pharmaceuticals Corporation) in 2021 for $2,700
    Subjects: Necrolytic Migratory Erythema; Pancreatic Neoplasms
    Categories: Complications; Etiology
    A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema. (2018)

  4. Ning, Guang    Google Publications
    Physician 
    Subjects: Gene Expression Regulation, Neoplastic; Glucagon; Insulin-Secreting Cells; Pancreatic Neoplasms; Proto-Oncogene Proteins
    Categories: Metabolism; Genetics; Physiology
    Conditional deletion of Men1 in the pancreatic β-cell leads to glucagon-expressing tumor development. (2015)

  5. Steffen, Hans-Michael    Google Publications
    Physician  Case Reports 
    Subjects: Pancreatic Neoplasms; Skin Neoplasms; Anemia; Diabetes Mellitus, Type 2; Stevens-Johnson Syndrome
    Categories: Diagnosis; Etiology; Pathology; Secondary
    Necrolytic migratory erythema due to glucagonoma. (2010)

  6. Halvorson, Stephanie A C   Hospitalist   Google Publications
    Division of Hospital Medicine, Department of Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, BTE-119, Portland, OR, 97239, USA, . Top Hospital
    Physician  Case Reports 
    Medical school: University of Minnesota Medical School (MD, 2001)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 80.3/100
    Subjects: Necrolytic Migratory Erythema; Pancreatic Neoplasms
    Categories: Diagnosis
    Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome. (2013)

  7. Goichot, Bernard    Google Publications
    Department of Internal Medicine, Endocrinology and Nutrition, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
    Physician  Case Reports 
    Subjects: Exanthema; Pancreatic Neoplasms; Psoriasis
    Categories: Complications; Etiology
    A Persistent Migrating Rash. (2018)

  8. Pahwa, Shivani   Neuroradiology  Google Publications
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 88/100
    Disclosed payments in 2021 from 13 biomedical companies, totalling $1,655.67, including $1,655.67 from  Medtronic, Inc.
    Subjects: Gallium Radioisotopes; Necrolytic Migratory Erythema; Organometallic Compounds
    Categories: Diagnostic Imaging
    Necrolytic migratory erythema associated with glucagonoma syndrome diagnosed by ⁶⁸Ga-DOTANOC PET-CT. (2014)

  9. Li, Li   Family Medicine  Google Publications
    Physician  Case Reports 
    Medical school: Other (MD, 1986)
    Medicare Accepted
    Disclosed payments in 2021 from 5 biomedical companies, totalling $83.05, including $83.05 from  Novo Nordisk Inc
    Subjects: Antineoplastic Agents, Hormonal; Hypercalcemia; Octreotide; Pancreatic Neoplasms
    Categories: Adverse Effects; Drug Therapy; Chemically Induced
    Hypercalcemia appeared in a patient with glucagonoma treated with octreotide acetate long-acting release. (2012)

  10. Navalkissoor, Shaunak    Google Publications
    Physician  Case Reports 
    Subjects: Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography
    Categories: Diagnostic Imaging; Therapy
    A Case Series of Molecular Imaging of Glucagonoma After Initial Therapy-68Ga-DOTATATE PET/CT Reveals Similar Results as in Neuroendocrine Tumors of Other Origin in Follow-up and Re-evaluation. (2018)

  11. Salopek, Thomas G   Dermatology  Google Publications
    Physician  Case Reports 
    Disclosed payments from biomedical company (Kyowa Kirin, Inc.) in 2021 for $1,626.02
    Subjects: Dermatitis; Necrolytic Migratory Erythema; Pancreatic Neoplasms; Terminology as Topic
    Categories: Pathology
    Is necrolytic migratory erythema due to glucagonoma a misnomer? A more apt name might be mucosal and intertriginous erosive dermatitis. (2012)

  12. Vantyghem, Marie-Christine    Google Publications
    Department of Endocrinology and Metabolism, Univ. Lille 2, INSERM UMR 1190, Lille, France.
    Physician 
    Subjects: Hepatocyte Nuclear Factor 3-beta; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms
    Categories: Metabolism; Biosynthesis
    Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas. (2017)

  13. Gotthardt, Martin    Google Publications
    Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
    Physician  Case Reports 
    Subjects: Multiple Endocrine Neoplasia Type 1
    Occult insulinoma, glucagonoma and pancreatic endocrine pseudotumour in a patient with multiple endocrine neoplasia type 1. (2020)

  14. Poligone, Brian   Dermatology  Google Publications
    Rochester Skin Lymphoma Medical Group, New York, USA.
    Physician  Case Reports 
    Disclosed payments in 2021 from 23 biomedical companies, totalling $27,142.24, including $19,448.68 from  Stemline Therapeutics Inc.
    Subjects: Necrolytic Migratory Erythema; Pancreatic Neoplasms
    Categories: Diagnostic Imaging; Diagnosis
    Necrolytic migratory erythema with recalcitrant dermatitis as the only presenting symptom. (2016)

  15. Gupta, Somesh    Google Publications
    Physician  Case Reports 
    Subjects: Gallium Radioisotopes; Necrolytic Migratory Erythema; Organometallic Compounds
    Categories: Diagnostic Imaging
    Necrolytic migratory erythema associated with glucagonoma syndrome diagnosed by ⁶⁸Ga-DOTANOC PET-CT. (2014)

  16. Li, Yanli    Google Publications
    Physician 
    Subjects: Gene Expression Regulation, Neoplastic; Glucagon; Insulin-Secreting Cells; Pancreatic Neoplasms; Proto-Oncogene Proteins
    Categories: Metabolism; Genetics; Physiology
    Conditional deletion of Men1 in the pancreatic β-cell leads to glucagon-expressing tumor development. (2015)

  17. Mahmood, Muhammad N   Endocrinology, Diabetes & Metabolism  Google Publications
    Physician  Case Reports 
    Disclosed payments in 2021 from 4 biomedical companies, totalling $82.11, including $51.98 from  Novo Nordisk Inc
    Subjects: Necrolytic Migratory Erythema; Octreotide
    Categories: Diagnosis; Drug Therapy; Therapeutic Use
    Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome. (2013)

  18. Ren, Jun    Google Publications
    Department of Dermatology, Zhongshan Hospital Xiamen University, Xiamen, China.
    Physician 
    Subjects: Necrolytic Migratory Erythema; Pancreatic Neoplasms
    Necrolytic migratory erythema-like eruption and paradoxical psoriasis associated with adalimumab treatment. (2021)

  19. Bodei, Lisa    Google Publications
    Physician  Case Reports 
    Subjects: Liver Neoplasms; Pancreatic Neoplasms; Cell Transformation, Neoplastic; Single Photon Emission Computed Tomography Computed Tomography
    Categories: Pathology; Diagnostic Imaging
    Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report. (2017)

  20. Gisondi, Paolo    Google Publications
    Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
    Physician  Case Reports 
    Subjects: Necrolytic Migratory Erythema
    Categories: Diagnosis
    VISUAL VIGNETTE. (2020)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);